On behalf of Mount Sinai, we would like to thank everyone for their participation and support for the COVID-19 hyperimmune globulin (HIG) program. Thanks to this community, we reached our goal for collection of high-quality convalescent plasma. Although the inpatient trials of receiving HIG have shown similar results to convalescent plasma trials, we are still assessing its use as a treatment in outpatient care as well as for prevention. We are very optimistic there will be important uses for COVID-19 HIG and hope the community will continue to support further trials.
Thank you for your continued support.
Copyright © 2021 Covidserum - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.